Gottlieb Touts FDA’s Plans for Real-World Evidence in Trials

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb on Monday outlined the agency’s plans for promoting the use of real world evidence in clinical trials in 2019.

To View This Article:

Login

Subscribe To Drug Industry Daily